Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025)
Akari Therapeutics (AKTX) posted quarterly Exchange Rate Effect of -$3000.0 for Q3 2025, down 250.0% year-on-year from $2000.0 in Q3 2024, and down 400.0% on a QoQ basis from $1000.0 in Q4 2024.
Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025) Analysis & Trends
Akari Therapeutics (AKTX) has reported Exchange Rate Effect for 8 consecutive years, with -$3000.0 the latest figure, recorded in Q3 2025.
- Quarterly Exchange Rate Effect fell 250.0% year-over-year to -$3000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$2000.0 (down 300.0% YoY) and the FY2025 annual result came in at $1000.0, up 125.0% from the prior year.
- Exchange Rate Effect fell to -$3000.0 in Q3 2025 per AKTX's latest filing, from $1000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for AKTX reached as high as $6000.0 in Q4 2023 and fell as low as -$5000.0 in Q1 2024.
- A 3-year average of -$285.71 and a median of -$1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect surged 300.0% — and 2025, when it sank 250.0%.
- Year by year, Exchange Rate Effect stood at $6000.0 in 2023, then sank by 83.33% to $1000.0 in 2024, then sank by 400.0% to -$3000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$3000.0, $1000.0, and $2000.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2020 | -21,401.00 |
| Dec 31, 2020 | -21,401.00 |
| Sep 30, 2020 | 275,701.00 |
| Sep 30, 2020 | 275,701.00 |
| Jun 30, 2020 | -5,924.00 |
| Jun 30, 2020 | -5,924.00 |